Cargando…

Which Vitamin D in CKD-MBD? The Time of Burning Questions

Vitamin D is a common treatment against secondary hyperparathyroidism in renal patients. However, the rationale for the prescription of vitamin D sterols in chronic kidney disease (CKD) is rapidly increasing due to the coexistence of growing expectancies close to unsatisfactory evidences, such as (1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galassi, Andrea, Bellasi, Antonio, Auricchio, Sara, Papagni, Sergio, Cozzolino, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3749554/ https://www.ncbi.nlm.nih.gov/pubmed/23991423 http://dx.doi.org/10.1155/2013/864012

Ejemplares similares

Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013)

The Role of Vitamin K in CKD-MBD
por: Fusaro, Maria, et al.
Publicado: (2022)

CKD-MBD KDIGO guidelines: how difficult is reaching the ‘target’?
por: Cozzolino, Mario
Publicado: (2018)

New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology
por: Bellasi, Antonio, et al.
Publicado: (2019)

CKD-MBD after kidney transplantation
por: Wesseling-Perry, Katherine, et al.
Publicado: (2011)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

CKD-MBD diagnosis: biochemical abnormalities
por: Lucca, Leandro Junior, et al.
Publicado: (2021)

Magnesium: a renewed player of vascular ageing in diabetic CKD patients?
por: Galassi, Andrea, et al.
Publicado: (2014)

Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
por: Magagnoli, Lorenza, et al.
Publicado: (2023)

Current Therapy in CKD Patients Can Affect Vitamin K Status
por: Cozzolino, Mario, et al.
Publicado: (2020)

Vitamin D and renal outcome: the fourth outcome of CKD-MBD? Oshima Award Address 2015
por: Hamano, Takayuki
Publicado: (2017)

Diagnosis of bone abnormalities in CKD-MBD (Imaging and bone biopsy)
por: Bucharles, Sérgio Gardano Elias, et al.
Publicado: (2021)

Clinical significance of parathyroid intervention on CKD-MBD management
por: Ogata, Hiroaki, et al.
Publicado: (2008)

The beneficial impact of vitamin D treatment in CKD patients: what's next?
por: Morrone, Luigi Francesco, et al.
Publicado: (2015)

Gaps between Global Guidelines and Local Practices in CKD-MBD
por: Kim, Gheun-Ho
Publicado: (2014)

CKD-MBD in Brazil: the gap between reality and the recommended guidelines
por: Custódio, Melani Ribeiro
Publicado: (2018)

Role of Chronic Kidney Disease (CKD)–Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD
por: Yamada, Shunsuke, et al.
Publicado: (2023)

Should We Consider the Cardiovascular System While Evaluating CKD-MBD?
por: Rroji, Merita, et al.
Publicado: (2020)

Testing Patterns for CKD-MBD Abnormalities in a Sample US Population
por: Wetmore, James B., et al.
Publicado: (2021)

Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
por: Vervloet, Marc G
Publicado: (2023)

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
por: Cozzolino, Mario, et al.
Publicado: (2017)

QT interval in CKD and haemodialysis patients
por: Di Iorio, Biagio, et al.
Publicado: (2013)

Circulating levels of sclerostin but not DKK1 associate with laboratory parameters of CKD-MBD
por: Behets, Geert J., et al.
Publicado: (2017)

Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD): Current Perspectives
por: Waziri, Bala, et al.
Publicado: (2019)

Magnesium—A More Important Role in CKD–MBD than We Thought
por: Peride, Ileana, et al.
Publicado: (2022)

Effects of diuretics furosemide and hydrochlorothiazide on CKD-MBD: A prospective randomized study
por: Vasco, Raquel F.V., et al.
Publicado: (2021)

Introduction: expanding concepts of chronic kidney disease-mineral and bone disorder (CKD-MBD)
por: Fukagawa, Masafumi, et al.
Publicado: (2013)

The Influence of Dietary Interventions on Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
por: Rysz, Jacek, et al.
Publicado: (2021)

Cinacalcet: the chemical parathyroidectomy?
por: Bellasi, Antonio, et al.
Publicado: (2013)

The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)—A Systematic Review
por: Pimentel, Ana, et al.
Publicado: (2021)

CKD Awareness in the General Population: Performance of CKD-Specific Questions
por: Tuot, Delphine S., et al.
Publicado: (2019)

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis
por: Block, Geoffrey A., et al.
Publicado: (2016)

Vitamin K in Chronic Kidney Disease
por: Cozzolino, Mario, et al.
Publicado: (2019)

Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan
por: Fukuma, Shingo, et al.
Publicado: (2013)

MBD2 and MBD3: elusive functions and mechanisms
por: Menafra, Roberta, et al.
Publicado: (2014)

Association of CKD-MBD Markers with All-Cause Mortality in Prevalent Hemodialysis Patients: A Cohort Study in Beijing
por: Li, Duo, et al.
Publicado: (2017)

Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease–Metabolic Bone Disease (CKD-MBD)
por: Rodriguez, Mariano, et al.
Publicado: (2018)

Association of Bone Mineral Density With Fractures Across the Spectrum of Chronic Kidney Disease: The Regina CKD-MBD Study
por: Prasad, Bhanu, et al.
Publicado: (2019)

Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats
por: Vorland, Colby J., et al.
Publicado: (2019)

Burning Questions
Publicado: (1894)

Cannot write session to /tmp/vufind_sessions/sess_9f1g5c9i3hmaglrtm4jl3kmdaf